Search images on Google Product Monograph
Active Ingredients:
- triprolidine hydrochloride, 2 MG/5 ML
- pseudoephedrine hydrochloride, 30 MG/5 ML
- guaifenesin, 100 MG/5 ML
- codeine phosphate, 10 MG/5 ML
DIN: 02053403
Dosage Form(s): SYRUP
Route(s) of Administration: ORAL
Schedule: Narcotic (CDSA I)
Company: TEVA CANADA LIMITED – official site
ATC:
- R05 - COUGH AND COLD PREPARATIONS (ATC, WHO, Wiki)
- R05F - COUGH SUPPRESSANTS AND EXPECTORANTS, COMBINATIONS (ATC, WHO)
- R05FA - Opium derivatives and expectorants (ATC, WHO)
- R05FA02 - OPIUM DERIVATIVES AND EXPECTORANTS (WHO)
Reference brand drug:
Packaging:
- Package size unit: No information
- Package type: No information
- Package size: No information
- Product information: 500ML/2L
Pharmaceutical standard: USP
External Links for Teva-Cotridin Expectorant:
Search on Google
- Teva-Cotridin Expectorant side effects
- Teva-Cotridin Expectorant dosage
- triprolidine hydrochloride side effects
- triprolidine hydrochloride dosage
- pseudoephedrine hydrochloride side effects
- pseudoephedrine hydrochloride dosage
- guaifenesin side effects
- guaifenesin dosage
- codeine phosphate side effects
- codeine phosphate dosage
Teva Canada Limited
Go to Teva website to see drug product details. Sometimes you can find teva-cotridin expectorant photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.